MoneyWorks4Me

Sanofi India board approves audited financial results

22 Feb 2018 Evaluate

With refer to letter dated 7th February 2018 Sanofi India has informed that the Board approved audited financial results for the year ended 31st December 2017 at its meeting scheduled today. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they hereby declare that the Statutory Auditors of the Company, Price Waterhouse & Co. Chartered Accountants LLP have issued the Audit Report with unmodified opinion for the financial year ended 31st December 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..